Earnings Call · Q3 FY2025·2025-11-19

Q3 25EPS +3.92%·Rev n/aQ2 25EPS -44.74%·Rev n/aQ1 25EPS -2.27%·Rev n/aQ4 24EPS +34.88%·Rev n/a⚠ consensus missing

Vivos Therapeutics, Inc. VVOS

Bradford Amman — CFO

R. Huntsman — Chairman and Chief Executive Officer

−10.2%1d on move date−8.6% vs SPY3d−8.9%5d−5.1%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VVOS calls or request research access.

More VVOS calls Browse calls Request research access